Carlos Spuch
Biographic Data
| ID | 7962070 |
|---|---|
| NAME | Carlos Spuch |
| GIVEN NAMES | Carlos |
| FAMILY NAME | Spuch |
| SIGNATURE | SPUCH C |
| AFFILIATIONS | Centro de Investigación en Red en Enfermedades Cardiovasculares |
| ORCID | 0000-0002-9161-0124 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Applied pharmacogenetics to predict response to treatment of first psychotic episode
The application of personalized medicine in patients with first-episode psychosis (FEP) requires tools for classifying patients according to their response to treatment, considering both treatment efficacy and toxicity. However, several limitations have hindered its translation into clinical practice. Here, we describe the rationale, aims and methodology of Applied Pharmacogenetics to Predict Response to Treatment of First Psychotic Episode (the …
Impairment in social cognition in people with substance use disorders
We discuss the clinical relevance of social cognition alterations and their potential utility in improving diagnostic and therapeutic processes for individuals with substance use disorders
Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study
Substance-related disorders (SRD) have been consistently associated with alterations both in cognitive and executive functions, which affect to patients' quality of life. The main objective of this work was to test the beneficial cognitive effects on patients with SRD after the implementation of "Trisquel," an intervention program in board game format. To check the effectiveness of Trisquel program, a group of people diagnosed with SRD was random…
Proteomics in Schizophrenia
Schizophrenia is a severe and disabling psychiatric disorder with a complex and multifactorial etiology. The lack of consensus regarding the multifaceted dysfunction of this ailment has increased the need to explore new research lines. This research makes use of proteomics data to discover possible analytes associated with psychoneuroimmune signaling pathways in schizophrenia. Thus, we analyze plasma of 45 patients [10 patients with first-episode…
No prominent works on this page.
Proteomics in Schizophrenia
Schizophrenia is a severe and disabling psychiatric disorder with a complex and multifactorial etiology. The lack of consensus regarding the multifaceted dysfunction of this ailment has increased the need to explore new research lines. This research makes use of proteomics data to discover possible analytes associated with psychoneuroimmune signaling pathways in schizophrenia. Thus, we analyze plasma of 45 patients [10 patients with first-episode…
Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study
Substance-related disorders (SRD) have been consistently associated with alterations both in cognitive and executive functions, which affect to patients' quality of life. The main objective of this work was to test the beneficial cognitive effects on patients with SRD after the implementation of "Trisquel," an intervention program in board game format. To check the effectiveness of Trisquel program, a group of people diagnosed with SRD was random…
Applied pharmacogenetics to predict response to treatment of first psychotic episode
The application of personalized medicine in patients with first-episode psychosis (FEP) requires tools for classifying patients according to their response to treatment, considering both treatment efficacy and toxicity. However, several limitations have hindered its translation into clinical practice. Here, we describe the rationale, aims and methodology of Applied Pharmacogenetics to Predict Response to Treatment of First Psychotic Episode (the …
Impairment in social cognition in people with substance use disorders
We discuss the clinical relevance of social cognition alterations and their potential utility in improving diagnostic and therapeutic processes for individuals with substance use disorders
Medicine (4 works) · Psychiatry (4 works) · Psychology (4 works) · Biology (2 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Genetics (2 works) · Psychotherapist (2 works) · Schizophrenia (object-oriented programming (2 works) · Substance use (2 works)